Target intelligence / Profile preview

Fibronectin leucine-rich transmembrane protein 2 (FLRT2)

Target
FLRT2
Molecular classification
Cell adhesion molecule, Transmembrane protein, Extracellular matrix-associated protein, Receptor-interacting protein, Other
01

Overview

Fibronectin leucine-rich transmembrane protein 2 (FLRT2) is a single-pass type I transmembrane protein that is part of the FLRT family. It contains an extracellular region with an N-terminal leucine-rich repeat domain and a type 3 fibronectin domain, a transmembrane region, and a short cytoplasmic tail. FLRT2 is primarily recognized for its roles in cell adhesion, cell migration, and axon guidance. It participates in both homophilic adhesion (FLRT2-FLRT2) and heterophilic interactions, especially with members of the UNC5 receptor family (notably UNC5B, UNC5D), and other proteins such as FGFR2 and LPHN2. Through these interactions, FLRT2 regulates signaling cascades essential for neural and vascular development, and has a recently described key function in promoting the differentiation of monocytes into macrophages by activating the Akt/mTOR pathway. FLRT2 is also implicated in osteoclast maturation and various human cancers, with context-dependent roles that can either suppress or promote tumor cell migration and adhesion. Aberrant epigenetic regulation of FLRT2 (e.g., promoter hypermethylation) has been linked with prostate, breast, and colorectal cancer. FLRT2 is broadly expressed in brain, heart, skeletal muscle, and certain immune cells, and its functions suggest potential as a disease biomarker and therapeutic target in immune, neurodevelopmental, and cancer contexts

Other names
Leucine-rich repeat transmembrane protein FLRT2KIAA0405UNQ232/PRO265Fibronectin-like domain-containing leucine-rich transmembrane protein 2FLRT2
02

Mechanism of action

Modulation of FLRT2 interacts with UNC5B to activate Akt/mTOR pathway (for differentiation); Epigenetic regulation (e.g., methylation patterns in cancer); Potential regulation via receptor activator of nuclear factor-κB ligand (RANKL) signaling in osteoclasts

03

Biological functions

Cell adhesionCell migrationAxon guidanceEmbryonic developmentNeural developmentVascular developmentMonocyte-to-macrophage differentiationOsteoclast multinucleationSignal transduction
04

Disease associations

CancerAutism spectrum disorderPotential biomarker/pronostic gene in stomach and prostate cancersOsteoclast-related bone diseaseOther
05

Safety considerations

No clinically validated safety concerns reportedpossible concern for targeting a developmental and adhesion molecule due to widespread expression during embryogenesis, neural, and vascular development
06

Interacting drugs

MYH1485 (an mTOR agonist that modulates FLRT2 pathway in experimental settings)
07

Biomarkers

Elevated FLRT2 expression as a signature gene in early-stage stomach cancer and prostatic adenocarcinomapromoter hypermethylation pattern in some cancers (breast, prostate, colorectal)

Beyond the preview

Go deeper on Fibronectin leucine-rich transmembrane protein 2 (FLRT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibronectin leucine-rich transmembrane protein 2 (FLRT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call